Cargando…
Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?
PURPOSE: To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. METHODS: The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/modera...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252694/ https://www.ncbi.nlm.nih.gov/pubmed/34213713 http://dx.doi.org/10.1007/s11255-021-02937-0 |
_version_ | 1783717352834072576 |
---|---|
author | Yasar, Emre Ozger, Hasan Selcuk Yeter, Hacı Hasan Yildirim, Cigdem Osmanov, Zakir Cetin, Taha Enes Akcay, Omer Faruk Bukan, Neslihan Derici, Ulver |
author_facet | Yasar, Emre Ozger, Hasan Selcuk Yeter, Hacı Hasan Yildirim, Cigdem Osmanov, Zakir Cetin, Taha Enes Akcay, Omer Faruk Bukan, Neslihan Derici, Ulver |
author_sort | Yasar, Emre |
collection | PubMed |
description | PURPOSE: To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. METHODS: The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients were evaluated again after an average of 21 days. RESULTS: The median (interquartile range) uKIM-1 level at the time of presentation was 246 (141–347) pg/mL in the proteinuric group, 83 (29–217) pg/mL in the non-proteinuric group, and 55 (21–123) pg/mL in the control group and significantly high in the proteinuric group than the others (p < 0.001). Creatinine and cystatin C were significantly higher in the proteinuric group than in the group without proteinuria, but none of the patients met the KDIGO-AKI criteria. uKIM-1 had a positive correlation with PCR, non-albumin proteinuria, creatinine, cystatin C, CRP, fibrinogen, LDH, and ferritin, and a negative correlation with eGFR and albumin (p < 0.05). In the multivariate regression analysis, non-albumin proteinuria (p = 0.048) and BUN (p = 0.034) were identified as independent factors predicting a high uKIM-1 level. After 21 ± 4 days, proteinuria regressed to normal levels in 20 (67%) patients in the proteinuric group. In addition, the uKIM-1 level, albuminuria, non-albumin proteinuria, and CRP significantly decreased. CONCLUSIONS: Our findings support that the kidney is one of the target organs of the COVID-19 and it may cause proximal tubule injury even in patients that do not present with AKI or critical/severe COVID-19 infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-021-02937-0. |
format | Online Article Text |
id | pubmed-8252694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-82526942021-07-02 Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection? Yasar, Emre Ozger, Hasan Selcuk Yeter, Hacı Hasan Yildirim, Cigdem Osmanov, Zakir Cetin, Taha Enes Akcay, Omer Faruk Bukan, Neslihan Derici, Ulver Int Urol Nephrol Nephrology - Original Paper PURPOSE: To evaluate urinary kidney injury molecule-1 (uKIM-1), which is a proximal tubule injury biomarker in subclinical acute kidney injury (AKI) that may occur in COVID-19 infection. METHODS: The study included proteinuric (n = 30) and non-proteinuric (n = 30) patients diagnosed with mild/moderate COVID-19 infection between March and September 2020 and healthy individuals as a control group (n = 20). The uKIM-1, serum creatinine, cystatin C, spot urine protein, creatinine, and albumin levels of the patients were evaluated again after an average of 21 days. RESULTS: The median (interquartile range) uKIM-1 level at the time of presentation was 246 (141–347) pg/mL in the proteinuric group, 83 (29–217) pg/mL in the non-proteinuric group, and 55 (21–123) pg/mL in the control group and significantly high in the proteinuric group than the others (p < 0.001). Creatinine and cystatin C were significantly higher in the proteinuric group than in the group without proteinuria, but none of the patients met the KDIGO-AKI criteria. uKIM-1 had a positive correlation with PCR, non-albumin proteinuria, creatinine, cystatin C, CRP, fibrinogen, LDH, and ferritin, and a negative correlation with eGFR and albumin (p < 0.05). In the multivariate regression analysis, non-albumin proteinuria (p = 0.048) and BUN (p = 0.034) were identified as independent factors predicting a high uKIM-1 level. After 21 ± 4 days, proteinuria regressed to normal levels in 20 (67%) patients in the proteinuric group. In addition, the uKIM-1 level, albuminuria, non-albumin proteinuria, and CRP significantly decreased. CONCLUSIONS: Our findings support that the kidney is one of the target organs of the COVID-19 and it may cause proximal tubule injury even in patients that do not present with AKI or critical/severe COVID-19 infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-021-02937-0. Springer Netherlands 2021-07-02 2022 /pmc/articles/PMC8252694/ /pubmed/34213713 http://dx.doi.org/10.1007/s11255-021-02937-0 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Nephrology - Original Paper Yasar, Emre Ozger, Hasan Selcuk Yeter, Hacı Hasan Yildirim, Cigdem Osmanov, Zakir Cetin, Taha Enes Akcay, Omer Faruk Bukan, Neslihan Derici, Ulver Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection? |
title | Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection? |
title_full | Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection? |
title_fullStr | Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection? |
title_full_unstemmed | Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection? |
title_short | Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection? |
title_sort | could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate covid-19 infection? |
topic | Nephrology - Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252694/ https://www.ncbi.nlm.nih.gov/pubmed/34213713 http://dx.doi.org/10.1007/s11255-021-02937-0 |
work_keys_str_mv | AT yasaremre couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection AT ozgerhasanselcuk couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection AT yeterhacıhasan couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection AT yildirimcigdem couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection AT osmanovzakir couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection AT cetintahaenes couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection AT akcayomerfaruk couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection AT bukanneslihan couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection AT dericiulver couldurinarykidneyinjurymolecule1beagoodmarkerinsubclinicalacutekidneyinjuryinmildtomoderatecovid19infection |